Atlas Trials

PharmaEssentia

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch PharmaEssentia

RecordFirmDate
Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera (NCT06290765)PharmaEssentia2026-08-01
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk (NCT06468033)PharmaEssentia2025-07-18
Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors (NCT07053904)PharmaEssentia2025-04-21
A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers (NCT06698861)PharmaEssentia2024-08-19
HLA-A*02:01 Allele Frequency and the NY-ESO-1 Expression Status in Cancer Patients in Taiwan (NCT06665776)PharmaEssentia2023-03-14
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV (NCT05481151)PharmaEssentia2022-10-26
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET (NCT05482971)PharmaEssentia2022-09-29
The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection (NCT04638439)PharmaEssentia2022-08-17
A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp (NCT05231044)PharmaEssentia2021-12-21
Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects (NCT05245578)PharmaEssentia2021-11-16
A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU (NCT05485948)PharmaEssentia2021-10-08
The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection (NCT04774107)PharmaEssentia2020-11-26

Track PharmaEssentia automatically

Every clearance here is in the API, with alerts when new ones post.